Mon panier

ActiveMax® Human DLL1 μBeads, premium grade (for cells, 20 μm)

Avis des utilisateurs
Numéro de produit/spécification
Prix
Qté
MBS-C041-2.5mg
$1788.00
ETA of in-stock products:2 business days
Total des articles Montant du produit$ 0

Détails du produit

  • Product
    Size
    Amount
    ActiveMax® Human DLL1 μBeads, premium grade (for cells, 20 μm)
    2.5 mg
    7.5×10⁵ beads
  • Product Description

    ActiveMax® Human DLL1 μBeads, premium grade (for cells, 20 μm) are uniform, superparamagnetic beads of 20 µm and coupled with Human DLL1 Protein, expressed from human 293 cells (HEK293) and contains AA Gln 18 - Gly 540 (Accession # O00548-1).
    ActiveMax® Human DLL1 μBeads, premium grade (for cells, 20μm) are produced under sterile manufacturing conditions (ISO 5), and no animal- or human-derived components are used throughout the production process. It is produced under our rigorous quality control system that includes a comprehensive set of tests including sterility and endotoxin tests.

  • Application

    ActiveMax® Human DLL1 μBeads, premium grade (for cells, 20 μm) activate Notch signaling in hematopoietic stem/progenitor cells (HSPCs) through DLL1 ligand-receptor engagement. It mimics DLL1+ thymic epithelial cells by presenting membrane-bound DLL1 ectodomains, driving T-lineage commitment via Notch-mediated transcriptional activation. It enables in vitro T cell differentiation from iPSC-derived sources, including the progression: CD34+ HSPCs → progenitor T cells → functional TCRαβ+ T cells. With standardized biochemical properties ensuring batch consistency, it provides both a research model for T cell development and a scalable platform for producing engineered T cell therapies from renewable stem cell sources.

  • Storage

    This product is stable in storage under the following conditions: -20˚C for 12 months in lyophilized state. -70°C for 3 months under sterile conditions after reconstitution.

    Please protect from light and avoid repeated freeze-thaw cycles. Immediate use after reconstitution is highly recommended.

  • Sterility

    Negative

  • Endotoxin

    Less than 0.002 EU per μg by the LAL method / rFC method.

  • Mycoplasma

    Negative

  • Important Note

    This product is for research use only and not intended for therapeutic or in vivo diagnostic use.

  • Formulation

    Lyophilized in PBS with 0.1% HSA, pH 7.4. Trehalose is added as protectant before lyophilization.

  • ACRO Quality Management System

    1. QMS(ISO, GMP)
    2. Quality Advantages
    3. Quality Control Process

Les clients ont également consulté

Affichage des données

  • FACS Data

     DLL1 FACS

    Assay of human DLL1 protein on the μBeads surface by Flow cytometry. The human DLL1 conjugated on the μBeads (Cat. No. MBS-C041) surface were fluorescently stained using PE anti-human Delta-like protein 1 (DLL1) Antibody, analyzed by flow cytometry (QC tested).

    Protocol

Avis des utilisateurs
Publier un commentaire

Progrès de frontière

 
Progrès du développement médicamenteux
  • Nom anglais:

    Delta Like Canonical Notch Ligand 1

  • Catégorie:

  • Nombre de médicaments répertoriés:

    0 Détails

  • Nombre de médicaments cliniques:

    0 Détails

  • Étape de développement la plus élevée:

    Preclinical

Drug Candidate Licensing
More
  • Informations de base sur le produit
  • Détails du produit
  • Les clients ont également consulté
  • Affichage des données
  • Avis des utilisateurs